InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Henneman John B III, Director. Director active across 9 companies, notably Anika Therapeutics, Inc.. In total, 30 disclosures have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €116k. Activity tracked since 18 May 2021. The latest transaction was filed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Henneman John B III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
10,402 sharesCommon StockSEC:0001193125-26-279542:0
3,135 sharesCommon StockSEC:0001104659-26-075282:0
14,164 shares0Common StockSEC:0001171843-25-004067:0
18,841 shares0Common StockSEC:0000950170-25-088989:0
1,045 shares0Common StockSEC:0001104659-25-057815:0
87,765 shares@ US$14.3090.9% of flowCommon StockSEC:0000950170-24-128856:0
5,771 shares0Common StockSEC:0001171843-24-003906:0
1,045 shares0Common StockSEC:0001104659-24-073941:0
15,152 shares@ US$12.87100.0% of flowCommon StockSEC:0000950170-24-075301:0
15,651 shares0Common StockSEC:0001628280-24-025050:0
6,860 shares@ US$7.29100.0% of flowCommon StockSEC:0001104659-24-034671:0
Canonical exit: 11 Jun 2024 (T+90)
500 shares0Common StockSEC:0001104659-23-095019:0
50,000 shares@ US$2.619.1% of flowCommon StockSEC:0001628280-23-028615:0
6,500 shares0Common StockSEC:0001171843-23-003959:0
11,324 shares0Common StockSEC:0001628280-23-019151:0
14,354 shares0Common StockSEC:0001209191-23-008128:0
82,654 sharesCommon StockSEC:0001637761-23-000041:0
14,052 shares0Common StockSEC:0001209191-23-002654:0
5,995 shares0Common StockSEC:0001104659-22-084765:0
54,751 sharesCommon StockSEC:0000899243-22-023862:0
60,790 sharesCommon StockSEC:0000899243-22-023836:0
7,954 shares0Common StockSEC:0001171843-22-004299:0
15,943 shares0Common StockSEC:0001637761-22-000096:0
5,151 sharesCommon StockSEC:0001628280-22-015245:0
4,610 shares0Common StockSEC:0001567619-21-012875:0
25 of 30 declarations
About Henneman John B III
HENNEMAN JOHN B III is Administrateur and has 30 filings in total. In the sampled recent filings between 2016-01-06 and 2026-06-23, the reported buy and sell amounts are EUR 115888 and EUR 1184569, with filings related to Anika Therapeutics, Inc., Aprea Therapeutics, Inc., R1 RCM Inc. /DE, Orthofix Medical Inc., SeaSpine Holdings Corp and NEWLINK GENETICS CORP.
